Minireviews
Copyright ©The Author(s) 2016.
World J Crit Care Med. Feb 4, 2016; 5(1): 89-95
Published online Feb 4, 2016. doi: 10.5492/wjccm.v5.i1.89
Table 1 Main observational studies evaluating steroid use in influenza infection
Ref.Study designPopulationSteroid regimenOutcomes
Bourdreault et al[33]Retrospective cohort143 hematopoietic cell transplant patients with seasonal influenzaPrednisone < 1 mg/kg per day (low dose) or prednisone > 1 mg/kg per day (high dose)Steroid use not associated with lower respiratory disease, hypoxemia, need for MV or death
Brun-Buisson et al[36]Retrospective cohort208 patients with ARDS due to H1N1 pneumonia, 83 receiving steroidsHydrocortisone 270 mg/d (median) for 11 d (median)Steroid was associated with mortality in crude analysis (33% vs 18%, HR = 2.4; 95%CI: 1.3-4.3; P = 0.004) and after propensity score-adjusted analysis (HR = 2.82; 95%CI: 1.5-5.4; P = 0.002)
Early therapy ( ≤ 3 d of MV) associated with increased mortality
Steroid associated with bacterial pneumonia and prolonged MV
Confalonieri et al[44]Case reportOne patient with ARDS due to H1N1 infection, not responding to antiviral therapyMethylprednisolone 1 mg/kg per dayClinical improvement
Cornejo et al[40]Case reportTwo patients with H1N1 that developed organizing pneumoniaMethylprednisolone 500 mg/d for 3 dClinical improvement
Diaz et al[37]Multicenter, prospective cohort372 patients with primary H1H1 pandemic pneumonia, 136 receiving steroidsNot reportedCorticosteroid therapy was not significantly associated with mortality (HR = 1.06; 95%CI: 0.626-1.801; P = 0.825) after a regression analysis adjusted for severity and potential confounding factors
Han et al[45]Multicenter, retrospective cohort83 patients with H1N1 pneumonia with hospitalar admission, 17 with early glucocorticoid treatmentMedian dose of methylprednisolone equivalent of 50 mg/d (use for fever reduction) to 61 mg/d (use for pneumonia)Early steroid treatment (< 72 h) was associated with development of critical disease compared with who received late (> 72 h) or no steroid treatment: 71% vs 39% (HR = 1.8; 95%CI: 1.2-2.8), after adjustment for confounding variables
Kim et al[35]Multicenter, retrospective cohort and case-control study245 patients with H1N1 infection, 107 with steroid treatmentMedian dose of prednisolone equivalent of 75 mg/d90-d mortality rate higher in steroids group (OR = 2.2; 95%CI: 1.03-4.71), after propensity score
Higher mortality both in cohort (58% vs 27%; P < 0.001) and case-control study (54% vs 31%; P = 0.004)
Steroid group more likely to have secondary bacterial pneumonia, invasive fungal infection and prolonged intensive care unit stay
Luyt et al[46]Multicenter, prospective cohort study37 survivors of ARDS due to H1N1 infection, 20 with steroid treatmentNot reportedNo relationship between steroid use and muscle weakness at 1-yr post-ICU discharge
Martin-Loeches et al[31]Multicenter, prospective cohort study220 patients with H1N1 infection, 126 with steroid treatment at ICU admissionMinimal equivalent dose of 24 mg/d (methylprednisolone) or 30 mg/d (prednisone)Early use of steroids was not significantly associated with mortality by Cox regression analysis adjusted for severity and confounding factors: HR = 1.3; 95%CI: 0.7-2.4; P = 0.4
Early steroid use associated with an increased rate of HAP (OR = 2.2; 95%CI: 1.0-4.8; P < 0.05) by Cox regression analysis
Similar results observed when only patiens with ARDS were analyzed
Patients who received early steroid therapy were sicker than who did not receive them according to SAPS 3 (55.9 ± 16.8 vs 49.0 ± 14.5; P = 0.001)
Quispe-Laime et al[47]Case series13 patients with suspected H1N1 pneumonia and ALI-ARDS diagnosisMethylprednisolone 1 mg/kg per day (severe ARDS) or hydrocortisone 300 mg/d. Duration of 21.2 ± 6.1 dTwelve patients improved lung function, were extubated and discharged alive from the ICU
By day 7 of treatment patients experienced a significant improvement in lung injury and multiple organ dysfunction scores (P < 0.001)